Literature DB >> 19876074

The vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans and its enhancement by allicin.

Hasibagan Borjihan1, Akira Ogita, Ken-ichi Fujita, Eiji Hirasawa, Toshio Tanaka.   

Abstract

In this study, the vacuole disruptive activity was evaluated as a cause of amphotericin B (AmB) lethality against the pathogenic fungus Candida albicans in terms of its enhancement by allicin, an allyl-sulfur compound from garlic. Vacuole disruption was observed in parallel to AmB-induced cell death when the antibiotic was used at a lethal concentration and at a non-lethal concentration in combination with allicin. Allicin did not enhance AmB-induced cell death and the accompanying vacuole disruption when the cells were incubated with exogenous ergosterol for its enrichment in the vacuole. The vacuoles isolated from intact cells could be directly disrupted by the action of AmB to the same extent in the absence and presence of allicin, whereas the organelles isolated from ergosterol-enriched cells were resistant to its direct disruptive action. AmB was similarly incorporated into the fungal cytoplasm in cells with or without ergosterol enrichment, supporting the fact that AmB-induced vacuole disruption depends on its direct disruptive action on the organelle. In agreement with these findings, allicin was found to inhibit ergosterol transport from the plasma membrane to the cytoplasm, which is considered to be a cellular protective response to AmB-induced vacuole disruption in S. cerevisiae. Our study suggests that AmB lethality against C. albicans depends at least in part on its vacuole disruptive activity under the physiological condition permissive for invasive growth of the fungus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19876074     DOI: 10.1038/ja.2009.103

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  8 in total

Review 1.  Antifungal adjuvants: Preserving and extending the antifungal arsenal.

Authors:  Arielle Butts; Glen E Palmer; P David Rogers
Journal:  Virulence       Date:  2016-07-26       Impact factor: 5.882

Review 2.  A comprehensive review on pharmacotherapeutics of herbal bioenhancers.

Authors:  Ghanshyam B Dudhatra; Shailesh K Mody; Madhavi M Awale; Hitesh B Patel; Chirag M Modi; Avinash Kumar; Divyesh R Kamani; Bhavesh N Chauhan
Journal:  ScientificWorldJournal       Date:  2012-09-17

3.  Alliinase from Ensifer adhaerens and Its Use for Generation of Fungicidal Activity.

Authors:  Masahiro Yutani; Hiroko Taniguchi; Hasibagan Borjihan; Akira Ogita; Ken-Ichi Fujita; Toshio Tanaka
Journal:  AMB Express       Date:  2011-03-28       Impact factor: 3.298

4.  Chemosensitization as a means to augment commercial antifungal agents.

Authors:  Bruce C Campbell; Kathleen L Chan; Jong H Kim
Journal:  Front Microbiol       Date:  2012-02-29       Impact factor: 5.640

5.  Quantitative and qualitative analysis of the antifungal activity of allicin alone and in combination with antifungal drugs.

Authors:  Young-Sun Kim; Kyung Sook Kim; Ihn Han; Mi-Hyun Kim; Min Hyung Jung; Hun-Kuk Park
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

6.  Enhancing effects on vacuole-targeting fungicidal activity of amphotericin B.

Authors:  Akira Ogita; Ken-Ichi Fujita; Toshio Tanaka
Journal:  Front Microbiol       Date:  2012-03-19       Impact factor: 5.640

7.  Proper Sterol Distribution Is Required for Candida albicans Hyphal Formation and Virulence.

Authors:  Paula McCourt; Hsing-Yin Liu; Josie E Parker; Christina Gallo-Ebert; Melissa Donigan; Adam Bata; Caroline Giordano; Steven L Kelly; Joseph T Nickels
Journal:  G3 (Bethesda)       Date:  2016-11-08       Impact factor: 3.154

8.  Modes of the antibiotic activity of amphotericin B against Candida albicans.

Authors:  Ewa Grela; Agnieszka Zdybicka-Barabas; Bozena Pawlikowska-Pawlega; Malgorzata Cytrynska; Monika Wlodarczyk; Wojciech Grudzinski; Rafal Luchowski; Wieslaw I Gruszecki
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.